Patient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular Atrial Fibrillation
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Atrial Fibrillation
- Sponsor
- Medical University of Graz
- Enrollment
- 91
- Locations
- 8
- Primary Endpoint
- Comparison of subjective stroke risk perception with CHA2DS2-VASc score
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
The risk of stroke is markedly elevated in patients with atrial fibrillation (AF). Oral anticoagulation (OAC) is indicated in individuals with moderate and high risk of stroke to the disadvantage of an increased burden from bleeding. Adequate knowledge of this disorder and understanding the benefits and hazards of antithrombotic treatment are essential to incorporate patient´s values and preferences in these decisions. This will further improve acceptance of recommended therapy and augment compliance with OAC.
The objective of this investigation is to compare patient´s perceptions and physician´s assessments of benefits and risks of OAC.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosed and ECG-documented non-valvular atrial fibrillation
- •New indication for oral anticoagulation (OAC)
- •Ability of informed consent
Exclusion Criteria
- •Existing OAC therapy
- •Valvular heart disease
- •History of valve surgery
Outcomes
Primary Outcomes
Comparison of subjective stroke risk perception with CHA2DS2-VASc score
Time Frame: Baseline
Comparison of subjective bleeding risk perception with HAS-BLED score
Time Frame: Baseline
Secondary Outcomes
- Relationship between accurate perception of stroke and bleeding risks and baseline parameters (highest completed level of education, subjective level of information)(Baseline)